Prospective Grant of Exclusive License: ``Diagnostic and Therapeutic Methods of Detecting and Treating Cancers of Reproductive Tissues''

Samenvatting

This is notice in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i) that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive world-wide license to the U.S. Patent Application 60/098,993, entitled, ``Diagnostic and Therapeutic Methods of Detecting and Treating Cancers of Reproductive Tissues'' and corresponding foreign patent applications to IDEC Pharmaceuticals, Inc. of San Diego, California. The United States of America is an assignee of the patent rights in these inventions and the contemplated exclusive license may be limited to the use of PAGE-4 plasmid DNA and/or PAGE-4 protein as a vaccine to produce an immune response in humans to eliminate PAGE-4 expressing prostate cancer cells.